Stalled Health Bill Means Regulatory Uncertainty for Drug Makers

President Obama’s proposed budget this week, for example, includes a plan he alluded to in last week’s State of the Union address: a new tax on profits from some patents and other intangible assets parked in overseas tax havens by American companies.“Pharma’s one that would really get hit,” said Erik Gordon, a professor at the Ross School of Business at the University of Michigan. “That’s a biggie.” via nytimes.com

Posted via web from Jack's posterous

• » Read Full Story